Tactile Systems Technology Inc
NASDAQ:TCMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Tactile Systems Technology Inc
Other Current Assets
Tactile Systems Technology Inc
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Tactile Systems Technology Inc
NASDAQ:TCMD
|
Other Current Assets
$8.1m
|
CAGR 3-Years
29%
|
CAGR 5-Years
25%
|
CAGR 10-Years
13%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Current Assets
$960m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
1%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Other Current Assets
$474.3m
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
|
Stryker Corp
NYSE:SYK
|
Other Current Assets
$1.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
22%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Other Current Assets
$2.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Current Assets
$376.4m
|
CAGR 3-Years
32%
|
CAGR 5-Years
24%
|
CAGR 10-Years
18%
|
|
Tactile Systems Technology Inc
Glance View
Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.
See Also
What is Tactile Systems Technology Inc's Other Current Assets?
Other Current Assets
8.1m
USD
Based on the financial report for Dec 31, 2025, Tactile Systems Technology Inc's Other Current Assets amounts to 8.1m USD.
What is Tactile Systems Technology Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
13%
Over the last year, the Other Current Assets growth was 60%. The average annual Other Current Assets growth rates for Tactile Systems Technology Inc have been 29% over the past three years , 25% over the past five years , and 13% over the past ten years .
